Elutia Inc - Ordinary Shares - Class A
ELUT - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$37.07M
Close$
$-0.63
175.4% downside
Current Fair Value
175.4% downsideOvervalued by 175.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $37.07 Million |
|---|---|
| Enterprise Value | $21.56 Million |
| Earnings per Share | $1.29 |
| Beta | 0.84 |
| Outstanding Shares | 43,622,360 |
Return
| Return on Equity | 329.02% |
|---|---|
| Return on Assets | 118.69% |
| Return on Invested Capital | -110.18% |
Valuation & Multiples
| P/E Ratio | 0.64 |
|---|---|
| PEG | -3.15 |
| Price to Sales | -0.84 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -20.47 |
| Enterprise Value to EBIT | -0.87 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.2 |
| Debt to Equity | 0.28 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
$-0.15
Consensus analyst estimateRevenue Estimate
$2.90 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.15
Consensus analyst estimateRevenue Estimate
$1.00 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Elutia Inc
162 employees
aziyo was created by highcape partners and tissue banks international with the mission of restoring health and mobility to the greatest number of patients. our vision for aziyo is to impact healthcare as the premier partner in innovation...